Osmium Compound Could Help Ovarian Cancer Patients Who Are Resistant to Platinum Therapies

Osmium Compound Could Help Ovarian Cancer Patients Who Are Resistant to Platinum Therapies
An organometallic compound called Organo-Osmium FY26 may be a promising therapy for ovarian cancer, according to a study. Researchers said FY26, which includes the metal osmium, may be able to kill ovarian cancer cells up to 50 times better than current platinum-based therapies. The researchers noted that FY26 uses a different mechanism than platinum therapies

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *